Literature DB >> 33760784

Access to Postpartum Sterilization: ACOG Committee Opinion, Number 827.

.   

Abstract

ABSTRACT: Sterilization is one of the most effective and popular forms of contraception in the United States, relied upon by 18.6% of women aged 15-49 years using contraception. Nearly half of procedures are performed during the postpartum period, yet many women who desire postpartum sterilization do not actually undergo the procedure. Factors that may decrease the likelihood of a patient obtaining desired postpartum sterilization include patient-related factors, physician-related factors, lack of available operating rooms and anesthesia, federal consent requirements, and receiving care in some religiously affiliated hospitals. In all discussions and counseling regarding contraception, including postpartum sterilization, it is important to engage in shared decision making while supporting personal agency and patient autonomy. Equitable access to postpartum sterilization is an important strategy to ensure patient-centered care while supporting reproductive autonomy and justice when it comes to decisions regarding family formation. This revision includes updates on barriers to postpartum sterilization and guidance for contraceptive counseling and shared decision making.
Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33760784     DOI: 10.1097/AOG.0000000000004381

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

Review 1.  Website Review of Variation in Individual State Medicaid Sterilization Policies.

Authors:  Heather Bouma-Johnston; Kavita Shah Arora
Journal:  Obstet Gynecol       Date:  2021-10-01       Impact factor: 7.623

Review 2.  Shared Decision-Making: The Way Forward for Postpartum Contraceptive Counseling.

Authors:  Brooke W Bullington; Asha Sata; Kavita Shah Arora
Journal:  Open Access J Contracept       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.